Cite
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
MLA
Sayegh N, et al. “Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma.” OncoTargets and Therapy, vol. ume 15, Sept. 2022, pp. 1047–55. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4fe8575bd4844b8bd357b694bcc52c0&authtype=sso&custid=ns315887.
APA
Sayegh N, Tripathi N, Agarwal N, & Swami U. (2022). Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma. OncoTargets and Therapy, ume 15, 1047–1055.
Chicago
Sayegh N, Tripathi N, Agarwal N, and Swami U. 2022. “Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma.” OncoTargets and Therapy ume 15 (September): 1047–55. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4fe8575bd4844b8bd357b694bcc52c0&authtype=sso&custid=ns315887.